Global Antibody Drug Conjugates Market Report By Type (Monoclonal Antibodies, Linker, Drug/Toxin, And Others), Application (Leukemia, Prostate Cancer, Kidney Cancer, Pancreas Cancer, Ovary Cancer, Glioblastoma, Lung Cancer, Colon Cancer, Breast Cancer, Skin Cancer, Solid Tumors, Multiple Myeloma, Lymphoma, And Other Cancers), Product (Adcertis, Kadcyla, And Others), Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, And Others), End-User (Hospitals, Specialized Cancer Centers, Academic Research Institutes, Biotechnology Companies, Biopharmaceutical Companie
ID:VMR11210482
February 2019
Report Formats:

As per this study the Global Antibody Drug Conjugates Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of XX.X%.

Antibody-drug conjugates or ADCs are amalgamate of antibody specific to the target associated antigen, a cytotoxic agent to kill cancer cells and a chemical linker to attach the cytotoxic agent to the antibody. ADCs are designed to kill only cancer cells without harming the other cells. Its general principle is to target a particular cell population.
 
Market Dynamics
 
The increasing number of patients suffering from cancer across the world along with rising consumption of tobacco and alcohol is driving the demand of ADCs. Also, food and drug administration (FDA) approval to the companies for antibody-drug conjugates is further fuelling the market growth. In addition, the growing collaborations between research institutes and biotechnology and biopharmaceutical companies are also expected to boost the market growth in upcoming years. Whereas, the high cost of procedures and lack of fund is anticipated to limit the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of antibody drug conjugates.
 
Market Segmentation
 
The broad antibody drug conjugates market has been sub-grouped into type, application, product, technology and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Types

  • Monoclonal Antibodies
  • Linker
  • Drug/Toxin
  • Others
 
By Application
  • Leukemia
  • Prostate Cancer
  • Kidney Cancer
  • Pancreas Cancer
  • Ovary Cancer
  • Glioblastoma
  • Lung Cancer
  • Colon Cancer
  • Breast Cancer
  • Skin Cancer
  • Solid Tumors
  • Multiple Myeloma
  • Lymphoma
  • Other Cancers
 
By Product
  • Adcertis
  • Kadcyla
  • Others
 
By Technology
  • Immunogen Technology
  • Seattle Genetics Technology
  • Immunomedics Technology
  • Others
 
By End-User
  • Hospitals
  • Specialized Cancer Centers
  • Academic Research Institutes
  • Biotechnology Companies
  • Biopharmaceutical Companies
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for antibody drug conjugates in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Antibody Drug Conjugates Market By Revenue (USD MN)
 
Europe Antibody Drug Conjugates Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the antibody drug conjugates market includes Abbvie Inc., Agensys, Inc., Antikor, Astellas Pharma/Agensys, Bayer Healthcare, Celldex Therapeutics, Concortis Biotherapeutics, Genentech, Heidelberg Pharma, Immunogen, Inc., Immunomedics, Mersana Therapeutics, Millennium Pharmaceuticals, Oxford Biotherapeutics, Pfizer Inc., Progenics Pharmaceuticals, Roche Holding Ag, Seattle Genetics and Synthon. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Antibody Drug Conjugates
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Antibody Drug Conjugates Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY TYPES
  • Market In Monoclonal Antibodies
  • Market In Linker
  • Market In Drug/Toxin
  • Market In Others
 
5. ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY APPLICATION
  • Market In Leukemia
  • Market In Prostate Cancer
  • Market In Kidney Cancer
  • Market In Pancreas Cancer
  • Market In Ovary Cancer
  • Market In Glioblastoma
  • Market In Lung Cancer
  • Market In Colon Cancer
  • Market In Breast Cancer
  • Market In Skin Cancer
  • Market In Solid Tumors
  • Market In Multiple Myeloma
  • Market In Lymphoma
  • Market In Other Cancers
 
6. ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY PRODUCT
  • Market In Adcertis
  • Market In Kadcyla
  • Market In others
 
7. ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY TECHNOLOGY
  • Market In Immunogen Technology
  • Market In Seattle Genetics Technology
  • Market In Immunomedics Technology
  • Market In Others.
 
8. ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY END-USER
  • Market In Hospitals
  • Market In Specialized Cancer Centers
  • Market In Academic Research Institutes
  • Market In Biotechnology Companies
  • Market In Biopharmaceutical Companies
  • Market In Others
 
9. ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
10. COMPETITIVE LANDSCAPE OF THE ANTIBODY DRUG CONJUGATES COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
11. COMPANY PROFILES OF THE ANTIBODY DRUG CONJUGATES INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Abbvie Inc.
  • Agensys, Inc.
  • Antikor
  • Astellas Pharma/Agensys
  • Bayer Healthcare
  • Celldex Therapeutics
  • Concortis Biotherapeutics
  • Genentech
  • Heidelberg Pharma
  • Immunogen, Inc.
  • Immunomedics
  • Mersana Therapeutics
  • Millennium Pharmaceuticals
  • Oxford Biotherapeutics
  • Pfizer Inc.
  • Progenics Pharmaceuticals
  • Roche Holding Ag
  • Seattle Genetics
  • Synthon
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Antibody Drug Conjugates
Table 2.  Global Antibody Drug Conjugates Market By Types
Table 3.  Global Antibody Drug Conjugates Market By Application
Table 4.  Global Antibody Drug Conjugates Market By Product
Table 5.  Global Antibody Drug Conjugates Market By Technology
Table 6.  Global Antibody Drug Conjugates Market By End-User
Table 7.  Global Antibody Drug Conjugates Market By Geography
Table 8.  North America Antibody Drug Conjugates Market
Table 9.  Europe Antibody Drug Conjugates Market
Table 10. Asia Pacific Antibody Drug Conjugates Market
Table 11. Latin America Antibody Drug Conjugates Market
Table 12. Middle East And Africa Antibody Drug Conjugates Market 
Table 13. Partnership/Collaboration/Agreements
Table 14. Mergers And Acquisitions
Table 15. New Product Development
Table 16. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Antibody Drug Conjugates Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Antibody Drug Conjugates
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Antibody Drug Conjugates Market By Types
Fig. 8.     Global Antibody Drug Conjugates Market By Application
Fig. 9.     Global Antibody Drug Conjugates Market By Product
Fig. 10.   Global Antibody Drug Conjugates Market By Technology
Fig. 11.   Global Antibody Drug Conjugates Market By End-User
Fig. 12.   Global Antibody Drug Conjugates Market By Geography
Fig. 13.   North America Antibody Drug Conjugates Market
Fig. 14.   Europe Antibody Drug Conjugates Market
Fig. 15.   Asia Pacific Antibody Drug Conjugates Market
Fig. 16.   Latin America Antibody Drug Conjugates Market
Fig. 17.   Middle East And Africa Antibody Drug Conjugates Market
Fig. 18.   Market Share Of Antibody Drug Conjugates Companies
Fig. 19.   Recent Developments In Antibody Drug Conjugates Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials